The Georgetown University Memory Disorders Program is dedicated to providing state-of-the-art clinical services for individuals affected by Alzheimer's disease and related disorders and to conducting research aimed at improving treatment options for Alzheimer's disease.

Glover Park Village Alzheimer's Talk

Carolyn Ward, MSPH will be speaking at the special program "Alzheimer's is a Family Affair" on Saturday October 25th. For more information on this and other events, see our news page.

Afternoon Tea with the MDP & the Alzheimer's Association Walk to End Alzheimer's®

For more information on these events, Click here.

Research Studies

Here are our research studies that are currently recruiting patients.

Title Sponsor
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4) ADCS/ Eli Lilly and Company

An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738 AM3) (EPOCH)

Merck

DOD-ADNI: A Study of Brain Aging in Vietnam War Veterans

ADCS

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Elan Pharmaceuticals

Effect of Passive Immunization on the Progression of Mild Alzheimer’s Disease: Solanezumab (LY2062430) versus Placebo

Eli Lilly and Company

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (NOBLE)

ADCS/Toyama Chemical Co.

Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019) (APECS)

Merck

Check out our Research section for more information on how to participate in our clinical trials.

Make a Donation

For information about how to make a tax-deductible contribution to the Memory Disorders Program, please click here.